Key statistics
On Friday, Syndax Pharmaceuticals Inc (SNDX:NSQ) closed at 18.27, 62.91% above the 52 week low of 11.22 set on Oct 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.64 |
---|---|
High | 18.69 |
Low | 18.24 |
Bid | 18.18 |
Offer | 18.24 |
Previous close | 18.63 |
Average volume | 1.56m |
---|---|
Shares outstanding | 85.10m |
Free float | 83.53m |
P/E (TTM) | -- |
Market cap | 1.55bn USD |
EPS (TTM) | -3.38 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Foundation Medicine Partners with Syndax to Develop a Companion Diagnostic in Hematology and Support Efforts to Pursue Regulatory Approval for an Assay Based on the FoundationOne®Heme Platform
- Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)